Metagenomi Therapeutics Inc MGX

$0.77 -0.04 (-4.74%)

Valuation

Market cap
30,433,000
Revenue TTM
$25,210,000
Net income TTM
$-87,870,000
PE ratio
0.00
Forward PE
—
Profit margin
-348.55%
Debt to equity
0.00

Trading

Volume
219,800
Avg volume
158,876
Day's range
$0.75 – $0.82
Shares out
37,777,000
Stochastic %K
9%
Beta
0.69
Analysts
Strong Sell
Price target
$7.00

Price

Company profile

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hype...

Show more

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 871 4880
Website
https://metagenomi.co
Address
5959 Horton Street, 7th Floor, EmeryVille, United States

Latest news

Stocktwits

MikeEhrmantraut Oct 26, 5:13 PM
$MGX pure grifters
0 replies
MikeEhrmantraut Oct 14, 4:00 PM
$MGX Timber!
1 replies
MikeEhrmantraut Sep 18, 9:34 PM
$MGX won’t be long until this slides under $1. Reverse split by end of next year.
1 replies
Trending__Now Sep 10, 7:11 PM
$MGX Swing play in at $1.17 IND EOY potential. Cash until 2027 and low current float. Why not?
0 replies
focafoca99 Aug 25, 2:23 PM
$MGX undergoes a law-firm investigation into alleged fiduciary breaches by its officers and directors.
1 replies
lediemhang00 Aug 24, 3:44 PM
$NXGL loaded some here. Still holding on to my $LUCY shares and $MGX after selling $MRNA last week
0 replies
anachartanalyst Aug 11, 2:02 PM
$MGX https://anachart.com/wp-content/uploads/2026/08/1786456911_soc-img.jpg
0 replies
pumpandumpslut Aug 7, 3:54 PM
$MGX awful quiet here...
0 replies